| Bioactivity | Rebamipide mofetil is an orally active prodrug of Rebamipide (OPC12759). Rebamipide is a mucoprotective agent. Rebamipide induces COX-2 expression, increases PGE2 levels, and enhances gastric mucosal defense in a COX-2-dependent manner[1]. | ||||||||||||
| Name | Rebamipide mofetil | ||||||||||||
| CAS | 1527495-76-6 | ||||||||||||
| Formula | C25H26ClN3O5 | ||||||||||||
| Molar Mass | 483.94 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Cho, Eui Hwan, et al.Pharmaceutical composition comprising rebamipide precursor for oral administration for preventing or treating immune disease and metabolic disease.WO2017138717A1. |
Rebamipide mofetil
CAS: 1527495-76-6 F: C25H26ClN3O5 W: 483.94
Rebamipide mofetil is an orally active prodrug of Rebamipide (OPC12759). Rebamipide is a mucoprotective agent. Rebamipid
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.